TRCT
NVOS

Tower Research Capital (TRC)’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Tower Research Capital (TRC)’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,702
Closed -$2.16K – 6195
2024
Q3 		$2.16K Buy
7,702
+986
+15% +$460 ﹤0.01% 5038
2024
Q2 		$5.04K Sell
6,716
-4,342
-39% -$2.78K ﹤0.01% 4724
2024
Q1 		$5.38K Buy
11,058
+2,060
+23% +$1.38K ﹤0.01% 4549
2023
Q4 		$7.39K Buy
+8,998
New +$18.3K ﹤0.01% 4616
2023
Q3 		– Sell
-4,882
Closed -$7.23K – 6385
2023
Q2 		$7.23K Sell
4,882
-3,303
-40% -$4.51K ﹤0.01% 4604
2023
Q1 		$10K Buy
8,185
+8,083
+7,925% +$10.7K ﹤0.01% 4443
2022
Q4 		$0 Sell
102
-879
-90% -$3.02K ﹤0.01% 6614
2022
Q3 		$10K Buy
981
+606
+162% +$9.85K ﹤0.01% 4604
2022
Q2 		$7K Sell
375
-49
-12% -$1K ﹤0.01% 4857
2022
Q1 		$10K Buy
424
+94
+28% +$1.56K ﹤0.01% 4391
2021
Q4 		$5K Buy
+330
New +$5.2K ﹤0.01% 5228
2021
Q3 		– Sell
-103
Closed -$3K – 6335
2021
Q2 		$3K Sell
103
-97
-49% -$2.42K ﹤0.01% 4978
2021
Q1 		$7K Buy
+200
New +$8.34K ﹤0.01% 4562

Other funds holding NVOS

AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Tower Research Capital (TRC)'s NVOS Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 7,702 shares — an estimated $2.16K sold.

Tower Research Capital (TRC) first reported a position in NVOS in Q1 2021 and held it in 13 quarters. The position peaked at $10K in Q1 2023. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 7,702 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $2.16K.
  • Tower Research Capital (TRC) first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Novo Integrated Sciences, Inc. Common Stock position peaked at $10K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.